These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16126283)

  • 1. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?
    Marchetti B; Abbracchio MP
    Trends Pharmacol Sci; 2005 Oct; 26(10):517-25. PubMed ID: 16126283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
    Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in central nervous system injury.
    Allan SM; Rothwell NJ
    Philos Trans R Soc Lond B Biol Sci; 2003 Oct; 358(1438):1669-77. PubMed ID: 14561325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and autoimmunity as a central theme in neurodegenerative disorders: fact or fiction?
    Clarkson AN; Rahman R; Appleton I
    Curr Opin Investig Drugs; 2004 Jul; 5(7):706-13. PubMed ID: 15298065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E; Delgado M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity.
    Schwartz M; London A; Shechter R
    Neuroscience; 2009 Feb; 158(3):1133-42. PubMed ID: 19103265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and the pathogenesis of neurodegenerative disorders.
    Reynolds A; Laurie C; Mosley RL; Gendelman HE
    Int Rev Neurobiol; 2007; 82():297-325. PubMed ID: 17678968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in the nervous system--physiological and pathophysiological aspects.
    Schultzberg M; Lindberg C; Aronsson AF; Hjorth E; Spulber SD; Oprica M
    Physiol Behav; 2007 Sep; 92(1-2):121-8. PubMed ID: 17597167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory mechanism of ginseng saponins in activated microglia.
    Park JS; Park EM; Kim DH; Jung K; Jung JS; Lee EJ; Hyun JW; Kang JL; Kim HS
    J Neuroimmunol; 2009 Apr; 209(1-2):40-9. PubMed ID: 19232442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response?
    Trendelenburg G
    J Cereb Blood Flow Metab; 2008 May; 28(5):867-81. PubMed ID: 18212795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear receptors, inflammation, and neurodegenerative diseases.
    Saijo K; Crotti A; Glass CK
    Adv Immunol; 2010; 106():21-59. PubMed ID: 20728023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma as a therapeutic target in central nervous system diseases.
    Sundararajan S; Jiang Q; Heneka M; Landreth G
    Neurochem Int; 2006 Jul; 49(2):136-44. PubMed ID: 16766086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
    Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
    Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic regulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216: implications for chronic treatments of neurodegenerative diseases.
    Bernardo A; Gasparini L; Ongini E; Minghetti L
    Neurobiol Dis; 2006 Apr; 22(1):25-32. PubMed ID: 16307889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria and the link between neuroinflammation and neurodegeneration.
    Di Filippo M; Chiasserini D; Tozzi A; Picconi B; Calabresi P
    J Alzheimers Dis; 2010; 20 Suppl 2():S369-79. PubMed ID: 20463396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-BIT Life Sciences' third annual world congress. Anti-neurodegenerative and anti-inflammation biotherapeutics.
    Filep JG
    IDrugs; 2010 Feb; 13(2):73-5. PubMed ID: 20127554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.